Arcadia Biosciences, Inc. (RKDA)
| Market Cap | 55.47M |
| Revenue (ttm) | 8.03M |
| Net Income (ttm) | -4.66M |
| Shares Out | 9.96M |
| EPS (ttm) | -0.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $2.60 |
| Previous Close | $2.48 |
| Change ($) | 0.12 |
| Change (%) | 4.84% |
| Day's Open | 2.48 |
| Day's Range | 2.48 - 2.60 |
| Day's Volume | 609,374 |
| 52-Week Range | 2.26 - 6.40 |
Will these 3 reddit penny stocks continue to perform next month? The post 3 Reddit Penny Stocks Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock...
Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) has said that three of its GoodHemp seed varieties have earned approval from Health Canada for consistency and compliance. The company said the Health Can...
DAVIS, Calif., April 20, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredient...
Arcadia Biosciences Inc (NASDAQ:RKDA) said it has acquired, through Arcadia SPA SL, the assets of Spanish food ingredients company Agrasys SA. By acquiring the physical and intellectual property assets...
DAVIS, Calif., April 19, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredient...
Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) posted fourth-quarter results on Wednesday that saw its revenue rocket nearly 1,606% year-over-year on the back of demand for its new wheat and hemp produ...
DAVIS, Calif., March 30, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.
On Tuesday, March 30, Arcadia Biosciences (NASDAQ:RKDA) will release its latest earnings report. Decipher the announcement with Benzinga's help.
DAVIS, Calif., March 23, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today announced ...
GoodWheat products includes flour enriched to be healthier, contain less gluten and last longer GoodHemp is a commercial brand of what it calls genetically superior hemp seeds Also has active nutritiona...
Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) reported that the US Patent and Trademark Office has awarded the company a patent for its high fiber resistant starch GoodWheat. Arcadia Biosciences noted...
DAVIS, Calif., March 2, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients,...
Arcadia Biosciences Inc (NASDAQ:RKDA) (FRA:17D) shares rose Wednesday as the agricultural biotech group said it had boosted its board with Debbie Carosella, a food industry executive and former manager ...
DAVIS, Calif., Feb. 24, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients,...
DAVIS, Calif., Dec. 22, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients,...
DAVIS, Calif., Dec. 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients,...
RKDA has had a number of important developments which I review here. They include: A transformative transaction in the HB4 soybean space.
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q3 2020 Results - Earnings Call Transcript
DAVIS, Calif., Nov. 12, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA) today announced a series of strategic transactions with Bioceres Crop Solutions Corp (NYSE: BIOX), including the sal...
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q2 2020 Results - Earnings Call Transcript
DAVIS, Calif., Aug. 13, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.
DAVIS, Calif., July 30, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.
Chinese Approval Of HB4 Soybeans Could Be A Major Catalyst For Arcadia Biosciences
DAVIS, Calif., July 6, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, ...
Arcadia Biosciences: An Update On Its Hemp/CBD Operations
DAVIS, Calif., May 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, ...
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q1 2020 Results - Earnings Call Transcript
Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q4 2019 Results - Earnings Call Transcript
Arcadia Biosciences Inc (NASDAQ: RKDA), a developer of food ingredients and nutritional oils, with some pre-existing hemp assets and a partnership with Shane Victorino, a former MLB player and son of th...
I'm Joining Insiders In Buying Arcadia Biosciences Stock
Arcadia Biosciences, Inc. (RKDA) CEO Matt Plavan on Q3 2019 Results - Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ: RKDA) reported third-quarter revenue of $392,000 on Wednesday, an increase from revenue of $370,000 in the same quarter in 2018.
Preview Of Q3 For Arcadia Biosciences
Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures.
USDA approval of soybean could be a major catalyst longer term for RKDA, potentially generating up to $125M in annual revenues at 60%+ margins.
Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA), announced this week plans for a new sun-grown hemp cultivation and agronomic ...
Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, respectively.
Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Compa...
Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q2 2019 Results - Earnings Call Transcript
Arcadia Biosciences (NASDAQ: RKDA) is expected to announce Tuesday a joint venture with Legacy Ventures Hawaii to grow, extract and sell superior hemp products, Benzinga has learned exclusively.
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences' (RKDA) CEO Rajendra Ketkar on Q1 2019 Results - Earnings Call Transcript
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q4 2018 Results - Earnings Call Transcript
In July of last year I explained why I wanted to have exposure to the agricultural genome-editing space, and after examining a few pure plays, I then went on to describe why Arcadia Biosciences was my f...
About RKDA
Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat... [Read more...]
| Industry Agricultural Inputs | IPO Date May 15, 2015 |
| Stock Exchange NASDAQ | Ticker Symbol RKDA |
Financial Performance
In 2020, RKDA's revenue was $8.03 million, an increase of 587.25% compared to the previous year's $1.17 million. Losses were -$4.66 million, -83.84% less than in 2019.
Analyst Forecasts
According to 2 analysts, the average rating for RKDA stock is "Buy." The 12-month stock price forecast is 6.45, which is an increase of 148.08% from the latest price.